NEW YORK, Dec. 11, 2025 — Keeper, the world’s most effective AI matchmaker, today announced it closed a $4 million pre-seed funding round in October 2024. The round was led by Lightbank and Lakehouse Ventures, with participation from Champion Hill Ventures, Goodwater Capital, and others. The funding has powered a year of R&D to automate Keeper’s revolutionary matching methodology and accelerate the company’s destiny to find lasting love for every person on Earth.
Keeper’s AI matchmaker helps users find highly compatible, long-term partners by screening thousands of options and presenting one tailored match at a time.
Founded in 2022, Keeper is the only matchmaking product that is singularly focused on outcomes, with a matching approach that emphasizes quality over quantity in the extreme and a business model that aligns the company’s incentives with user success. In beta, Keeper’s comprehensive intake and psychometric approach attracted more than 1.5 million signups and produced the best success rate of any product in history with 1-in-10 first dates leading to marriage.
Since closing the round in October 2024, Keeper has focused on turning its human-in-the-loop, AI-assisted process into a fully automated AI matchmaker. With the recent launch of Keeper V2, Keeper’s AI performs the heavy lifting–searching, ranking, and proposing matches–before an expert human matchmaker performs a brief final review. This preserves accuracy while compressing time-to-match as Keeper completes the transition to full automation.
“In beta, we proved that our method works. This past year has been about scale, speed, and accessibility,” said Jake Kozloski, Founder & CEO of Keeper. “Our AI is becoming the matchmaker that understands you better than you understand yourself–so your first match can be your last first date. This funding helped us build the foundation for a fully automated AI matchmaker that can address loneliness at a global scale.”
Keeper uses open-ended data collection and rigorous relationship science to assess compatibility across preferences, personality, values, intelligence, and other predictors of long-term success. The company’s algorithms–developed with guidance from Stanford evolutionary scientists and psychometricians–learn from real-world outcomes to continuously improve matching performance.
John Neamonitis at Lakehouse Ventures recognizes Keeper’s promise: “Dating apps have one of the lowest NPS among all consumer apps–users are tired and frustrated and ready for something new. With advances in large language models, an AI matchmaker isn’t just possible, but as Keeper is proving, infinitely better than incumbent solutions.”
The new capital is being used to scale Keeper’s unrivaled matching engine, expand distribution, and introduce self-improvement features like coaching and feedback so Keeper can defeat industry incumbents whose products don’t work and make human loneliness a thing of the past.
Keeper is the AI matchmaker committed to finding everyone their soulmate. By combining advanced AI with relationship science and a business model aligned to user success, Keeper aims to end loneliness and give everyone the opportunity to build a happy, healthy family.
New funding accelerates the company’s North American expansion, strengthens passive income opportunities for drivers and enhances partnerships with nationwide brands and agencies
LOS ANGELES, Dec. 11, 2025 — Stic, the technology-enabled platform that connects brands with everyday drivers to power measurable out-of-home (OOH) advertising, today announced it has raised a $10 million Bridge funding round led by Accretion Capital and notable entrepreneurs like Phil Hellmuth, Adam Waheed and Chris Detert. Advisory support came from experts such as Lucy Guo, Maurice Maschmeyer, Tanya Cohen, Collins Key, Devan Key, Kamo Jurn and the Global Wealth Solutions Group of Raymond James.
The latest investment brings Stic’s total valuation to $200 million and supports the company’s mission to create simple, passive earning opportunities for everyday drivers while giving brands a more measurable, and cost-efficient approach to OOH. Over the next year, Stic will use the new capital to expand operations across more than thirty US states and Canada, deepen relationships with brands and agencies running national campaigns and strengthen its operational capabilities in new markets.
“By combining a fast-growing driver network with powerful analytics, we’re giving brands a scalable way to run OOH campaigns while putting money back into people’s pockets,” said Adam Cohen, founder and CEO of Stic. “Stic makes it easier for people to earn passive income without changing their daily routines and this funding helps us bring that opportunity to more communities while giving brands a more measurable way to reach high value audiences in the real world.”
Founded in 2023, Stic’s platform brings greater measurement, transparency and scale to a part of OOH that has long been fragmented and difficult to track. Brands can use the platform to activate campaigns across Stic’s driver network, and drivers earn money per mile for participating. Stic uses a mix of proprietary systems and industry-standard mapping, mobility and analytics tools to model routes, traffic patterns and campaign performance, delivering modern transparency from streets to the screen.
The company currently works with a broad range of national and emerging brands across the insurance, retail, technology, CPG, QSR and entertainment categories. Since its inception, Stic’s driver network has grown by 600%, helping transform the gig economy with a model that eliminates the time, labor and constant engagement required by most platforms while giving brands a uniquely human and highly efficient advertising channel. The platform supports real people, brings enhanced transparency to the industry and elevates expectations for what OOH advertising can deliver.
“As a partner, working with Stic supports the best of both human empowerment and smart technology,” said Lucy Guo, CEO/founder of Passes and co founder of Scale AI. “In today’s economy, people are looking for meaningful ways to earn income and seek advertising that isn’t disruptive to their daily lives. Stic’s platform empowers gig workers while delivering smarter advertising in the real world, unlocking growth opportunities for all sides of the marketplace— from drivers to brands and agencies.”
About Stic Stic is a VC-backed adtech startup transforming the way brands and consumers think about outdoor advertising by turning everyday vehicles and gig economy vehicles into measurable, mobile media. Founded in 2023, Stic enables drivers to earn money simply by going about their daily routines, using removable, technology-enabled stickers that track mileage, optimize ad placement, and calculate real-time impressions.
Salesforce Ventures, Motivate Ventures, DCG, ex/ante, and Cambrian Ventures invest as Cyphlens expands its advisory board with leading security and intelligence experts.
NEW YORK, Dec. 11, 2025 — Cyphlens is defining the next generation of enterprise security with visual encryption, a groundbreaking layer of protection that lives everywhere the eye meets the screen. Today, the company announced the close of its oversubscribed $3.8 million seed round and the expansion of its world-class advisory board. The round includes participation from Salesforce Ventures, Motivate Ventures, DCG, ex/ante, and Cambrian Ventures — underscoring strong investor conviction in this new category of data protection.
Cyphlens’ patented visual encryption technology introduces a new layer of defense to enterprise security by protecting information at the moment it’s viewed — the last mile where traditional encryption stops. The company’s flagship product, Cyph-lens, transforms sensitive data into encrypted visual ciphers readable only through a secure decoding lens, preventing exposure even when displayed on screen. This technology addresses the rapid rise of AI-driven phishing, credential theft, screen-scraping malware, and insider risks across complex digital supply chains.
In a cybersecurity market crowded with incremental advances, Cyphlens stands apart by securing what others overlook – the moment data is viewed. Its visual encryption technology fills a critical gap left open by traditional encryption and access management solutions, delivering true end-to-end protection for the AI era.
“In a cybersecurity market full of incremental improvements, Cyphlens is solving a blind spot: data exposure at the point of view,” said Rob Keith, Partner at Salesforce Ventures. “Their visual encryption architecture extends true zero-trust security to the last mile — where data is most vulnerable — and arrives at exactly the right moment as enterprises grapple with AI-accelerated threats.”
“Our mission is to make the strongest security invisible – so adoption becomes instinctive,” said Rocky Motwani, CEO of Cyphlens. “With Cyphlens, visual encryption can be added to existing systems in minutes, extending zero-trust protection to every endpoint and every user.”
Industry Leaders Join Cyphlens Advisory Board
Cyphlens has appointed several leading figures from cybersecurity, intelligence, and fintech to its advisory board:
Chris Moretti, VP of Global Technology & AI Infrastructure Enablement at Cigna – bringing an enterprise-scale perspective on secure data access and digital transformation.
Chris Novak, Founder of the Verizon Threat Research Advisory Center, a globally recognized authority on cyber risk and threat intelligence.
William MacMillan, a former Chief Information Security Officer at the CIA, offers decades of experience in national security and intelligence operations.
Richard Grogan-Crane, CEO of XTRM, contributes deep expertise in financial services and payments security.
Together, these advisors strengthen Cyphlens’ position as a leader in visual encryption and next-generation identity access management.
“Cyphlens is building for the future of enterprise security – one where AI, scale, and usability must coexist,” said Chris Novak. “Their architecture anticipates tomorrow’s threats while simplifying how enterprises protect what matters most.”
Cyphlens will use the new funding to accelerate product development across its visual-encryption platform, deepen enterprise integrations, and expand engineering and customer-success teams. The company is also scaling go-to-market efforts to meet rising demand from financial services, government, and healthcare organizations seeking stronger protection against AI-driven data exposure.
About Cyphlens
Cyphlens pioneers visual encryption to combat emerging threats in identity access management and data security. Its technology protects information even when viewed – safeguarding against AI-driven phishing, insider threats, and supply-chain vulnerabilities.
Cyphlens’ solutions are deployed across financial services, government, and healthcare sectors, helping organizations safeguard critical data, strengthen authentication, and maintain trust in an era of accelerated digital and AI risk.
The company continues to expand its platform capabilities with upcoming products, including CypherFile, which extends visual encryption to files and shared documents, and CypherMFA, a next-generation multi-factor authentication system that leverages visual encryption and delegation by design for seamless, zero-friction identity verification.
Emerging leader in security data pipelines has raised $22M in 15 months, expanded headcount 250%, and helped CISOs slash six figures in SIEM ingestion costs
BOSTON, Dec. 11, 2025 — Realm.Security, the company pioneering the industry’s first AI-native Security Data Pipeline Platform (SDPP), today announced a $2M strategic investment from Presidio Ventures, the corporate venture arm of Japanese-headquartered Sumitomo Corporation. A global integrated trading company with a history spanning 400 years, Sumitomo operates numerous subsidiaries around the world, including SCSK, a leading global system integrator, providing managed IT and cybersecurity services to more than 8,000 enterprise customers. Realm will use the investment and access to Sumitomo’s network to accelerate its Asia-Pacific expansion through channel partners and further strengthen its executive team.
“We’re excited to bring on Presidio Ventures as a strategic investor as we meet rising global demand for our platform from security teams who are drowning in data noise and facing spiraling storage and compute costs,” said Pete Martin, co-founder and CEO of Realm.Security. “This investment caps an impressive first full calendar year for Realm, and we believe Sumitomo’s deep connections will help us enter the Asia-Pacific market and scale quickly in 2026. The region is now the third-largest cybersecurity market globally, and Japan is a particularly compelling entry point for our channel-led strategy, given that many enterprises there outsource their Security Operation Centers.”
“Realm is using AI to give every enterprise security team the ability to manage, filter, and normalize security data in ways that, until recently, were only possible for Fortune 1000 companies with dedicated cybersecurity data engineering teams,” said Ross Leav of Presidio Ventures. “We’re excited to join their mission to democratize this capability as the cybersecurity industry faces a data crisis. At the same time, the industry also faces a human resource crisis. Especially in Japan where talented cyber professionals are becoming an increasingly scarce resource, enterprises need to find ways to do more with less. This is a perfect opportunity to employ AI, both to meet the challenge of data overload but also to enable cyber professionals to focus their attention on the most critical threats. We believe Realm can be an essential tool for modernizing our own security operations services while at the same time improving outcomes for the many customers who rely on us.”
The strategic investment follows a $15M Series A round for Realm in October, led by Jump Capital and including participation from Glasswing Ventures and Accomplice. Other recent milestones include Realm being recognized as an “Emerging Leader” in the SDPP category in analyst firm SACR’s “The Rise of Security Data Pipeline Platforms as a Control Plane for the SOC report,” as well as receiving a BostInno 2025 Fire Award as one of the 50 companies having a major impact on the local startup ecosystem. More impressively, Vensure Employer Solutions, a 10,000-person benefits and payroll provider, recently reported using Realm’s platform to cut firewall log volumes by 83%, saving $250,000 annually.
To fuel its momentum and global expansion, Realm.Security is continuing to scale its team, increasing headcount by 250% in 2025. Recent leadership appointments include Holly Cappello as Chief Revenue Officer and Colin Jermain as Vice President of Data Science. Cappello brings more than a decade of cybersecurity sales experience, most recently serving as SVP of Global Sales at Cado Security, which was acquired by Darktrace. She previously held senior sales roles at Menlo Security and Carbon Black. Jermain joins from SecurityScorecard, where he was Senior Director of Data Science, and previously served in multiple senior data science roles at Vectra AI. These appointments underscore Realm’s continued investment in revenue, data, and AI leadership as it enters its next phase of growth.
About Realm.Security
Realm.Security helps security teams cut costs and improve outcomes by transforming how they manage and route security data. Headquartered in Boston, the company was founded by industry veterans with decades of experience defending against evolving threats. Realm’s AI-native Security Data Pipeline Platform is radically simple to deploy and operate, embedding artificial intelligence across the platform to deliver faster, smarter outcomes without the manual overhead. Learn more atwww.realm.security.
About Presidio Ventures Presidio Ventures is the corporate venture capital arm of Sumitomo Corporation, one of the world’s leading integrated trading companies. With offices in Silicon Valley, Boston, New York, London and Los Angeles, it has invested in more than 200 companies, providing both financial backing and business development expertise to help startups scale globally. www.presidio-ventures.com.
Avocet to Acquire EMC National Life, Establishing a Nationally Licensed Annuity and Life Insurance Platform
NEW YORK, Dec. 11, 2025 — Avocet Partners (“Avocet” or the “Company”) today announced its launch as a new insurance-focused investment and operating platform backed by $500 million of committed equity capital from funds managed by Oaktree Capital Management, L.P. (“Oaktree”) and Lane42 Investment Partners, LLC (“Lane42”).
Led by an experienced founding team of operators with a proven track record of building, scaling, and managing insurance platforms across multiple market cycles, Avocet was formed to acquire, operate and grow life insurance platforms and establish an ecosystem of related investment and service entities. The Avocet founding team brings decades of experience as insurance operators with prior senior leadership roles across leading insurers and insurance-focused investment firms.
Concurrent with its launch, Avocet has entered into a definitive agreement to acquire EMC National Life Insurance Company (“EMC Life”) from EMC Insurance. The acquisition provides Avocet with a nationally licensed platform operating in 48 states and a skilled team of approximately 80 professionals based in Des Moines, Iowa. Additional information on the transaction can be found in EMC Insurance’s announcement here.
EMC Life will serve as the foundational carrier for Avocet’s strategy to build a scaled, multi-line life and annuity insurance organization. Avocet plans to invest substantial capital to enhance EMC Life’s operations and support new growth initiatives, including the launch of annuity products distributed through independent marketing organizations and other strategic channels, alongside continued expansion of EMC Life’s life insurance business.
Jagan Pisharath, Founder & CEO of Avocet Partners stated: “We are thrilled to launch Avocet in partnership with Oaktree and Lane42, two institutions that share our vision for building a platform focused on growing leading insurance companies with aligned asset management expertise to help policyholders secure retirement solutions in a time of growing need. The acquisition of EMC Life is the cornerstone of our permanent capital platform. We are not simply acquiring a company and a strong team — we are investing in a long-term strategy to build a premier, highly-rated annuity and life insurance carrier.”
“With Avocet, Jagan and his team are applying deep sector expertise and a disciplined growth strategy to a segment of the insurance market with compelling long-term fundamentals,” said Thomas Casarella and Zach Serebrenik of Oaktree’s Special Situations strategy. “EMC Life provides a strong operating base, and we believe Avocet is well positioned to invest strategically in the business, expand its product offerings, and build a scaled platform over time.”
“Lane42 is pleased to support Jagan and the Avocet team as they work to create a leading, differentiated life and annuity platform that meets the growing needs of the market,” commented Lane42 Partner Trevor Winstead. “Under the leadership of seasoned, accomplished insurance executives and with the acquisition of EMC Life providing the foundation, Avocet is positioned for meaningful, sustained growth.”
“On behalf of the entire EMC Life senior management team, including Mark DeVries and Paul Rivard, I want to express how proud we are of the innovative and tech-enabled platform our team members have built,” said Chris Frazier, President & COO of EMC Life. “We are excited to become part of Avocet Partners and believe their industry expertise, operational capabilities, and long-term capital will position EMC Life for its next phase of growth as part of a scaled insurance platform.”
Avocet’s acquisition of EMC Life is expected to close in 2026, subject to customary closing conditions, including regulatory approvals and the demutualization of the EMC National Life Mutual Holding Company. EMC Life will be renamed at or shortly after the closing.
Kirkland & Ellis LLP and Latham & Watkins LLP served as legal counsel, and Oliver Wyman acted as actuarial advisor to Avocet. Piper Sandler & Co. acted as financial advisor to EMC Life in connection with the transaction. Nyemaster Goode acted as legal counsel to EMC. Faegre Drinker acted as legal counsel to EMC National Life Mutual Holding Company.
About Avocet Partners Avocet Partners is focused on acquiring and growing insurance companies. The firm is led by seasoned executives with a proven record of quickly scaling businesses and is backed by leading institutional investors. Avocet leverages deep industry insight and long-term investment discipline to create value across the insurance ecosystem.
About Oaktree Oaktree is a leader among global investment managers specializing in alternative investments, with $218 billion in assets under management as of September 30, 2025. The firm emphasizes an opportunistic, value-oriented, and risk-controlled approach to investments in credit, equity, and real estate. The firm has more than 1,400 employees and offices in 26 cities worldwide. For additional information, please visit Oaktree’s website at www.oaktreecapital.com.
About Lane42 Investment Partners Lane42 Investment Partners is an alternative asset management firm specializing in capturing the most compelling opportunities for value creation from inefficiencies in public and private markets and the convergence of debt and equity financing across asset classes. Lane42’s mission is to deliver value to investors and exceptional partnership to portfolio companies, driven by a culture of integrity, collaboration, and alignment. Founded by Scott L. Graves, an accomplished investment professional with more than 30 years of public and private credit and equity investing, Lane42 was seeded with a $2 billion capital commitment and a minority equity investment from affiliates of Millennium Management LLC. Lane42 is headquartered in Santa Monica and New York. www.Lane42.com.
About EMC Life EMC National Life (EMC Life) is the life affiliate of EMC Insurance, an insurance enterprise that has been in business for more than 100 years. EMC Life is dedicated to providing superior service and simple products that make life easy.
Next Generation Intratumoral Technology Targets Diffuse Intrinsic Pontine Glioma
Investigational New Drug Enabling Studies are Underway with Planned Clinical Trial to Begin Late 2026
FORT WORTH, Texas, Dec. 11, 2025 — NanOlogy, LLC, a private clinical-stage oncology company, is pleased to announce its drug development program aimed at transforming the treatment of diffuse intrinsic pontine glioma (DIPG), an aggressive highly lethal pediatric brainstem tumor. The company is developing Large Surface Area Microparticle (LSAM) Cisplatin for stereotactic intratumoral (IT) administration in this initial indication.
Plans for Pediatric Clinical Trials
NanOlogy is completing Investigational New Drug (IND) enabling studies required by the U.S. Food and Drug Administration (FDA). Upon completion of these studies, the company plans to submit an IND application for LSAM-Cisplatin to treat malignant neoplasms of the brain including DIPG. Subject to FDA allowance to proceed, NanOlogy aims to initiate a clinical trial in late 2026 to evaluate the safety and response of stereotactic IT administration of LSAM-Cisplatin in children diagnosed with DIPG. According to DIPG.org, DIPG afflicts 150 – 300 children annually in the United States, with median survival of less than one year. Current treatments, like radiation therapy, may delay progression but almost always fail to deliver long term survival. NanOlogy is also assessing future opportunities to extend the use of LSAM-Cisplatin to treat other brain and solid tumors.
The Promise of LSAM-Cisplatin in DIPG
In laboratory research studies, cisplatin has been shown to kill DIPG tumors by binding to DNA and disrupting cell replication, leading to cell death. Unfortunately, current systemically administered cisplatin formulations are associated with numerous severe side effects throughout the body. In addition, cisplatin does not cross the blood brain barrier well, limiting its efficacy in brain tumors, making systemically administered cisplatin a suboptimal treatment for DIPG.
“We believe NanOlogy’s innovative LSAM-Cisplatin investigational drug designed for intratumoral administration can overcome the limitations of current treatment options with highly targeted delivery of drug into the tumor, continuous drug release, and minimal systemic toxicity,” said H. Paul Dorman, founder and chairman of NanOlogy. “Advancements in minimally invasive surgical procedures and imaging now allow local delivery of LSAMs to solid tumors virtually anywhere in the body, including the brain. We are excited to advance IT LSAM-Cisplatin for DIPG and explore the promise it may hold for children and families facing this devastating disease.”
About NanOlogy
NanOlogy, LLC (www.nanology.us) is a private clinical-stage oncology company developing treatments for solid tumors using drugs optimized for intratumoral delivery designed to improve response with minimal to no systemic toxicity. Enabled by the CritiTech Particle Engineering Solutions’ Purcision™ technology platform, NanOlogy produces Large Surface Area Microparticles (LSAMs) of pure drug for direct local delivery overcoming issues of systemic toxicity and tumor bioavailability. NanOlogy clinical programs have advanced LSAM investigational drugs in multiple solid tumors including pancreas, lung, bladder, peritoneal, ovarian, prostate, and dermal cancers. Feasibility of the Purcision™ platform has been established in taxanes, platins, tyrosine kinase inhibitors, poly (ADP-ribose) polymerase inhibitors, and other agents. The investigational drugs are covered by composition of matter patents issued in the United States and other major jurisdictions worldwide, including Canada, Europe, Japan, China, South Korea, Australia, and India, which form the foundation of an extensive intellectual property portfolio of over 100 issued patents protecting NanOlogy investigational drugs, formulations, methods, and technology.
TORRANCE, Calif., Dec. 11, 2025 — K2 Space, the California-based developer of large, high-power satellite platforms, today announced a $250 million Series C at a $3 billion valuation, accelerating delivery of a new generation of spacecraft built for the heavy-lift era. The financing follows $500 million in signed contracts across commercial and U.S. government customers and is led by Redpoint, with participation from accounts advised by T. Rowe Price Associates, Inc., and from Hedosophia, Altimeter, Lightspeed, and Alpine Space Ventures.
K2 Space’s GRAVITAS satellite undergoes final integration before its March 2026 flight
K2 was founded in 2022 on a single thesis: the rise of launch vehicles like Falcon 9, Starship and New Glenn will make it possible to build an entirely new category of satellite. Satellites that are larger, higher power and more reliable; that can be deployed in any orbit – LEO, MEO, and GEO – rather than confined to one. These capabilities will become increasingly important as critical applications like communications and compute get pushed from terrestrial networks to space.
“Space is becoming one of the most strategically important technology sectors, and it’s attracting investment because the underlying demand is real and accelerating,” said Elliot Geidt, Partner at Redpoint. “What stands out about K2 is how much core hardware they’ve built themselves. They’re not assembling a satellite; they’re redefining the architecture needed for the next decade of missions.”
“K2 is tackling one of the biggest limitations in the space economy: meaningful increases in power and scale,” said T. Rowe Price investment analyst Jason Leblang. “Their approach isn’t incremental. They’re rethinking satellite design from the ground up, and the result is a platform that can support entirely new classes of missions. That’s why we’re confident in the team and the trajectory.”
Building the technical base for the next class of missions
K2’s first two years were spent solving what the commercial supply chain hadn’t: the foundational subsystems required for large, high-power, highly resilient spacecraft. The team designed the highest power hall-effect thruster ever flown – 4x more powerful than anything that’s flown to-date; large solar arrays, designed to reliably generate maximum power; a radiation-tolerant avionics suite built to survive high radiation environments; massive reaction wheels; high voltage power systems; and much more.
Those designs weren’t just theoretical. Earlier this year, K2 flew its hardware as part of a hosted-payload mission that validated the flight computer, reaction wheel, and avionics stack in space, de-risking the core of the platform ahead of full-system integration.
“Each subsystem had to be built to a new performance class,” said Neel Kunjur, Co-Founder and CTO. “That engineering forms the basis of our high-power ‘Mega’ line, and it’s why we can take customers beyond the limits of the small-satellite era.”
Four months to launch: The Mega Class satellite
In March 2026, K2 will launch GRAVITAS, the company’s first production of its “Mega Class” satellite. While small relative to what K2 is designing next, the Mega Class satellite is on par with the largest satellites that have ever been produced. Mega is designed to fly on today’s workhorse rockets, including Falcon 9, Vulcan, and Ariane 6, while delivering approximately 10× the power of other satellites in its class. Built from the outset for multi-orbit operations, Mega is hardened for some of the harshest environments in the solar system and engineered with redundancy and reliability techniques historically reserved for human-rated vehicles like Dragon and the Space Shuttle.
The mission represents K2’s first spaceflight of the fully integrated, in-house system and will open a comprehensive test campaign:
The first in-space firing of a 20 kW Hall-effect thruster – roughly 4× more powerful than anything flown to date.
The first deployment of the large twin 10 kW solar arrays on the platform (20kW total).
The first on-orbit exercise of K2’s high-voltage power system paired with radiation-tolerant avionics.
“GRAVITAS brings our full stack together for the first time,” said Karan Kunjur, Co-Founder and CEO. “We are validating the architecture in space, from high-voltage power and large solar arrays to our guidance and control algorithms, and a 20 kW Hall thruster, and we will scale based on measured performance.”
“We pushed our propulsion hard on the ground and were thrilled to hot-fire at the full 20 kW,” added Rafael Martinez, who leads K2’s high-power electric propulsion program. “Now we’re eager to characterize the thruster’s performance in space.”
From first flight to full-rate production
Following Mega’s launch, K2 will ramp manufacturing at its 180,000 –sq.-ft. Torrance factory, sized to produce 100 high-power satellites per year. That capacity will be needed as K2 starts delivering against $500 million in signed commercial and government contracts. Customers include large operators like SES, who recently announced plans to partner with K2 on its future MEO network. Multiple launches across 2026-2027 are planned, with operational commercial and national security constellations beginning deployment starting in 2028.
“K2 is bringing something brand new to the space industrial base: low cost, high power satellites produced at speed and scale,” said Dr. John Plumb, Head of Strategy at K2. “Our innovative approach will enable entire satellite constellations of exquisite payloads – something unimaginable due to its prohibitive cost before K2 showed up.”
Next up: Giga, built for super-heavy lift
With Mega establishing the production baseline, K2 will next unveil plans for designing Giga: its large-class spacecraft designed specifically for Starship and New Glenn. Giga will deliver 100kW of power per satellite, enabling missions that previously only existed in science fiction:
AI scale compute on orbit
High-throughput networks spanning orbits – and planets
Mass-produced giant telescopes to vastly expand scientific return from across the solar system and beyond
“Our north star is simple,” said Karan Kunjur. “If we build these platforms well, we get to ask new questionsabout what’s possible in orbit.”
About K2 Space At K2 Space, we’re Building Bigger.
K2 is building the largest and highest-power satellites ever flown, unlocking performance levels previously out of reach across every orbit.
By scaling capability and production, K2 delivers systems ready for the most demanding missions – from national security and global communications to deep-space research – with reliable performance wherever they operate.
Founded by former SpaceX engineers, K2 Space has raised more than $450M from leading investors including Altimeter Capital, Redpoint, accounts advised by T. Rowe Price Associates, Inc., Lightspeed Venture Partners, and Alpine Space Ventures.
MIAMI, Dec. 11, 2025 — In the high-stakes world of professional sports, “innovation” is often reduced to buying better equipment or signing more expensive players. But for Ilya Movshovich, Managing Partner at Digital Athlete Ventures and owner of Cobh Ramblers FC, true innovation isn’t about spending more, it’s about seeing differently.
Ilya Movshovich, Managing Partner, Digital Athlete Ventures
While the industry largely relies on tradition and intuition, Ilya Movshovich is applying the rigorous, data-driven disciplines of Venture Capital to the unpredictable world of football. The result is a new blueprint for ownership: one that views a sports club not as a vanity asset, but as a scalable technology platform.
The Thesis: Arbitrage in the Locker Room
“The sports industry is filled with inefficiencies,” says Ilya Movshovich. “And where there is inefficiency, there is opportunity.”
At Digital Athlete Ventures, the core philosophy is identifying value where others see noise. Ilya Movshovich has taken this VC thesis, normally reserved for Silicon Valley startups, and applied it directly to the operations of Cobh Ramblers FC.
The strategy is distinct: treat the club as a high-growth ecosystem. While traditional owners obsess over the final score, Ilya Movshovich obsesses over the leading indicators, the systemic, often invisible metrics that predict long term success. This is an innovative approach to “asset management” that prioritizes sustainable infrastructure over short term fixes.
Innovative Approaches: Measuring the “Unmeasurable”
Where most clubs look at physical data (speed, distance, strength), Ilya Movshovich drives results by looking for the “hidden” data points that actually dictate the game.
1. Cognitive Analytics & The Digital Mind The next frontier in sports isn’t physical; it’s mental. However, the industry has historically treated mental performance as a soft skill, impossible to measure. Ilya Movshovich disagreed.
The Innovation: By integrating advanced cognitive assessment tools into the club’s regimen, Ilya Movshovich is digitizing the mental game. The club creates profiles based on decision making speed, spatial awareness, and cognitive resilience under pressure.
The Strategic Edge: This allows the club to recruit and develop players based on their “processing power,” not just their athleticism. It is a market inefficiency that Ilya Movshovich is exploiting to build a squad that thinks faster than the opposition.
2. Vertical Integration of Talent In the tech world, controlling your supply chain is critical. In football, that “supply chain” is the Academy.
The Innovation: Rather than treating the youth system as a lottery, Ilya Movshovich utilizes data modeling to track developmental trajectories years in advance. This is “Talent R&D.” By investing heavily in the systems that produce players, the club reduces its reliance on the volatile transfer market. It’s a move away from the “buy talent” model to a “build talent” model, securing long term asset value.
3. The Club as a Platform Traditional thinking separates the “business” from the “team.” Ilya Movshovich integrates them. By treating the club as a digital media platform, Ilya Movshovich has unlocked new revenue streams through global digital engagement, rather than relying solely on local ticket sales.
The Innovation: This approach decouples revenue from match day results, creating a stable financial baseline that allows the club to take calculated risks on the pitch that other clubs cannot afford to take.
The “Digital Athlete” Vision
This convergence of strategy leads to what Ilya Movshovich defines as the “Digital Athlete”-a holistic view of the player where health, performance, and psychology are interconnected through data.
“We don’t guess,” Ilya Movshovich asserts. “In Venture Capital, you don’t invest based on a feeling; you invest based on the unit economics and the team’s capacity to execute. We run the club the same way. We use technology to de-risk our decisions.”
Conclusion: The Innovator’s Advantage
In an industry that is notoriously resistant to change, Ilya Movshovich is proving that the greatest competitive advantage is a willingness to break the mold. By bridging the gap between the boardroom of Digital Athlete Ventures and the dugout of Cobh Ramblers FC, Ilya Movshovich is doing more than just planning on winning games.
They are here to demonstrate that when you treat sports with the intellectual rigour of a tech venture, you find results in places where no one else is even looking.
About Digital Athlete Ventures (DAV)
Digital Athlete Ventures (DAV) is a sports and media investment firm that acquires majority stakes in sports teams across the globe.
HUNTINGTON, N.Y., Dec. 11, 2025 — Sen-Jam Pharmaceutical, a clinical-stage biotechnology company pioneering novel anti-inflammatory combination therapeutics, today announced a transformative partnership with TASK Clinical, a global contract research organization (CRO). Under the agreement, TASK Clinical will fund two-thirds of the upcoming Phase 3 clinical trial for SJP-001 in exchange for equity — an exceptionally rare commitment that significantly de-risks development, enhances investor confidence, and strengthens the program for global licensing opportunities.
This milestone follows Sen-Jam’s recent announcement appointing Rute Fernandes, a seasoned global life-sciences executive with leadership roles across Takeda, Shire, and Novartis, as Executive Advisor to accelerate commercialization pathways.
A Synergistic Partnership Network: TASK Clinical + KVK Tech
Sen-Jam now benefits from a vertically integrated development ecosystem:
TASK Clinical providing clinical leadership and majority funding of Phase 3
KVK Tech, Sen-Jam’s established corporate venture partner/CMO, driving formulation, CMC, and FDA submission readiness
Rute Fernandes guiding global market expansion and commercialization strategy
KVK Tech has made significant progress in the formulation development and CMC work for SJP-001, including the manufacturing of GMP batches. Upon completion of the ongoing Phase 2 dose-ranging study, KVK Tech will finalize the FDA submission batches, enabling a rapid transition into Phase 3 and subsequent regulatory filing.
This powerful alignment ensures Sen-Jam is de-risked across clinical, manufacturing, operational, and commercial dimensions — a rare position for a company at this stage.
Quotes from Leadership
Jim Iversen, Co-Founder & CEO, Sen-Jam Pharmaceutical
“This partnership with TASK Clinical reflects a shared belief in the scientific and commercial potential of SJP-001. Having a global CRO take an equity position in our pivotal Phase 3 trial is a powerful signal to investors and future licensing partners. Combined with KVK Tech’s formulation and CMC execution and Rute’s commercial leadership, Sen-Jam is entering the strongest phase in its history.“
Johann de Bruyn, Chief Executive Officer, TASK Clinical
“We chose to invest directly in Sen-Jam and fund the majority of the Phase 3 program because we believe SJP-001 has the potential to be a first-in-category global therapy. It is uncommon for a CRO to assume an equity position in a pivotal trial, but Sen-Jam’s science, strategy, and team earned our confidence. We are proud to partner with Sen-Jam and look forward to executing a world-class Phase 3 study together.”
“TASK Clinical’s commitment to fund the majority of Phase 3 is a powerful validation of Sen-Jam’s scientific foundation and strategic direction. I have rarely seen a CRO take such a substantial equity position in a sponsor’s pivotal program. The strength of this partnership, combined with the manufacturing readiness provided by KVK Tech, significantly de-risks SJP-001 for investors and accelerates our pathway to global licensing and commercialization. I am thrilled to help guide Sen-Jam in turning this momentum into widespread impact.“
SJP-001: A First-in-Category Opportunity
SJP-001 is Sen-Jam’s lead combination therapy designed to modulate the inflammatory cascade triggered by alcohol consumption — the underlying biological cause of next-day symptoms such as headache, malaise, nausea, and cognitive impairment. If approved, SJP-001 could become the first FDA-regulated hangover-prevention therapeutic, representing a first-in-category commercial opportunity in an underserved global market.
The Phase 2 trial, conducted by Cliantha Research in Toronto, Canada, was completed in November with data readout and final analysis expected Q1 2026.
Growing Visibility: Jackie Iversen’s TEDx Talk
Momentum continues to build through Co-Founder Jackie Iversen’s recent TEDx Talk “How Mastering Hangovers Reveals the Science of Longevity“, spotlighting the critical role of inflammation in human health and the urgent need for accessible, science-backed innovation. Her talk has broadened awareness of Sen-Jam’s mission, reinforcing the company’s leadership at the intersection of inflammation science and global health transformation.
A De-Risked, Licensing-Ready Therapeutics Company
Sen-Jam now represents one of the most attractive emerging assets in inflammation therapeutics, supported by:
De-risked Phase 3 funding via TASK
Manufacturing and regulatory readiness through KVK Tech
Seasoned commercial leadership from Rute Fernandes
Global thought leadership highlighted through TEDx
A first-in-category therapeutic backed by robust scientific rationale
Together, these elements position Sen-Jam for accelerated investor engagement, strategic partnership development, and global licensing discussions.
About Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical is transforming the management of inflammation through novel, low-cost, combination therapeutics designed for safety, efficacy, and global accessibility. Its proprietary PAIR platform targets inflammatory cascades across acute and chronic conditions. Lead programs include SJP-001 for alcohol-induced inflammation and SJP-002C for viral respiratory symptoms. For more information, visitwww.wefunder.com/senjam.
About TASK Clinical
TASK Clinical is a global contract research organization specializing in multi-site, late-phase clinical trials. With expertise spanning North America, Europe, and emerging markets, TASK delivers comprehensive development support and operational excellence to accelerate the approval and commercialization of innovative therapeutics.
About KVK Tech
KVK Tech is an FDA-approved pharmaceutical manufacturer specializing in formulation development, CMC execution, and large-scale commercial production. As Sen-Jam’s corporate venture partner, KVK Tech has led the formulation and CMC work for SJP-001 and will complete the FDA submission batches necessary for the upcoming Phase 3 program.
CONTACT INFORMATION: Sen-Jam Pharmaceutical Christine Leonard 781-913-1902 [email protected]
